Psychedelic Stocks,Shroom News Mydecine Reports Annual Financial Results for 2020 By Dennis Mutua May 05, 2021 Biopharma and Life Sciences company dedicated to research, development and commercialization of innovative treatments to mental illness patients Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) has released its financial result...
Featured,Spotlight Stock,Trends & Articles Champignon Brands Changes its Name to Braxia Scientific Corp By Dennis Mutua May 04, 2021 Medical solutions company specializing on using novel and natural products with an emphasis on psychedelics to treat mental illnesses Champignon Brands Inc. (CSE: SHRF) (OTCQB: SHRMF) announced changing its name to Braxia Scientif...
Psychedelic Stocks,Shroom News Tryp Partners With Fluence to Provide Medical Therapy Training By Dennis Mutua May 04, 2021 Pharmaceutical company specializing on developing novel clinical stage compounds to treat orphan diseases and various mental conditions Tryp Therapeutics Inc. (CNSX: TRYP) (OTCQB: TRYPF) announced having entered a partnership with...
Featured,Spotlight Stock,Trends & Articles Maine Seeking to Legalize Psychedelics for Adults Over 21 By Dennis Mutua May 03, 2021 A proposal seeking to allow adults over 21 years old in Maine State to legally buy and use psychedelics under the supervisor of a certified psilocybin health officer has been filed. The bill also seeks to legalize psilocybin mushr...
Psychedelic Stocks,Trends & Articles MindMed Plunges Following its NASDAQ Uplisting By Dennis Mutua April 30, 2021 In the beginning of the week, biotech company focusing on discovering, developing and deploying psychedelic-inspired drugs Mind Medicine Inc. (MNMD) secured an uplist from the Over The Counter (OTC) market to the NASDAQ. This w...
Featured,Shroom News,Spotlight Stock Lobe Life Sciences Files for Key PCT Application By Dennis Mutua April 30, 2021 Life sciences company specializing on psychedelics therapies for mental illness patients Lobe Life Sciences Ltd. (CSE: LOBE) (OTC: GTSIF) announced having submitted application for key Patent Cooperation Treaty (PCT) titled ‘Met...
Featured,Spotlight Stock,Trends & Articles PharmaDrug Granted FDA Orphan Drug Designation of DMT for Prevention of Ischemia-Reperfusion Injury During Organ Transplant By Dennis Mutua April 29, 2021 Biotechnology company focused on development and commercialization of natural medicine and controlled substances including cannabis and psychedelics PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) announced having been granted U.S. Food ...
Psychedelic Stocks,Shroom News Delix Therapeutics Releases Study Results Showing Therapeutic Potential for a Psychedelic Analogue Without Hallucinogenic Effects By Dennis Mutua April 29, 2021 Preclinical pharmaceutical company developing small molecule drug compound intended to assist providing therapies for mental illness patients Delix Therapeutics released results of a highly regarded scientific study. According ...